ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

242 filings reported holding SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 83,632,743 shares of 98,567,360 outstanding shares and own 84.85% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10,860,977 shares), ORBIMED ADVISORS LLC (8,288,510 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (7,503,812 shares), BlackRock, Inc. (4,831,327 shares), Rubric Capital Management LP (4,500,000 shares), SR One Capital Management, LP (4,012,903 shares), VANGUARD GROUP INC (3,500,303 shares), Aberdeen Group plc (3,097,022 shares), STATE STREET CORP (2,895,256 shares), and ALLIANCEBERNSTEIN L.P. (2,642,111 shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.